levodopa has been researched along with trifluoperazine in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (38.46) | 18.7374 |
1990's | 3 (23.08) | 18.2507 |
2000's | 2 (15.38) | 29.6817 |
2010's | 3 (23.08) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Dill, RE; Dorris, RL; Phillips-Thonnard, I | 1 |
Bonnet, K; Friedhoff, AJ; Tosengarten, H | 1 |
Jenner, P; Marsden, CD | 1 |
Berry, T | 1 |
Boyce, S; De Ceballos, ML; Jenner, P; Marsden, CD | 1 |
Dawson, R; Felheim, R; Phillips, MI | 1 |
Radwany, SM; Rich, MW | 1 |
Casadevall, A; Wang, Y | 1 |
Sampaio-Maia, B; Soares-Da-Silva, P | 1 |
Fraga, S; Sampaio-Maia, B; Serrão, MP; Soares-da-Silva, P | 1 |
2 review(s) available for levodopa and trifluoperazine
Article | Year |
---|---|
Chronic pharmacological manipulation of dopamine receptors in brain.
Topics: Acetylcholine; Animals; Antipsychotic Agents; Brain; Bromocriptine; Corpus Striatum; Enkephalin, Leucine; Enkephalin, Methionine; Levodopa; Pergolide; Receptors, Dopamine; Trifluoperazine | 1987 |
Respiratory dyskinesia. An underrecognized phenomenon.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Dyskinesia, Drug-Induced; Humans; Levodopa; Male; Middle Aged; Phenothiazines; Prevalence; Respiration Disorders; Risk Factors; Trifluoperazine | 1994 |
11 other study(ies) available for levodopa and trifluoperazine
Article | Year |
---|---|
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
A pharmacologic model of Huntington's chorea.
Topics: Animals; Carbachol; Catheterization; Clozapine; Corpus Striatum; Disease Models, Animal; Dyskinesia, Drug-Induced; Haloperidol; Huntington Disease; Hydrazines; Levodopa; Male; Phentolamine; Rats; Trifluoperazine; Tyramine | 1976 |
Reversal of two manifestations of dopamine receptor supersensitivity by administration of L-dopa.
Topics: Adenylyl Cyclases; Animals; Corpus Striatum; Depression, Chemical; Dopamine; Haloperidol; In Vitro Techniques; Levodopa; Rats; Receptors, Dopamine; Trifluoperazine | 1977 |
L-dopa for the negative symptoms of schizophrenia.
Topics: Drug Therapy, Combination; Humans; Levodopa; Schizophrenia; Schizophrenia, Paranoid; Schizophrenic Psychology; Trifluoperazine | 1988 |
Alterations in [Met5]- and [Leu5]enkephalin and neurotensin content in basal ganglia induced by the long-term administration of dopamine agonist and antagonist drugs to rats.
Topics: Animals; Basal Ganglia; Bromocriptine; Carbidopa; Dopamine; Dopamine Antagonists; Enkephalin, Leucine; Enkephalin, Methionine; Levodopa; Male; Neurotensin; Pergolide; Rats; Rats, Inbred Strains; Trifluoperazine | 1986 |
Dopamine receptor agonists and antagonists both inhibit dopamine secretion in LLC-PK1 cells.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Aromatic-L-Amino-Acid Decarboxylases; Benzazepines; Cell Line; Chlorpromazine; Chromatography, High Pressure Liquid; Dopamine; Dopamine Agents; Dopamine Antagonists; Epithelial Cells; Epithelium; Ergolines; Fenoldopam; Kidney; Levodopa; Phenothiazines; Quinpirole; Trifluoperazine | 1993 |
Susceptibility of melanized and nonmelanized Cryptococcus neoformans to the melanin-binding compounds trifluoperazine and chloroquine.
Topics: Chloroquine; Cryptococcus neoformans; DNA, Fungal; Dopamine Agents; Dopamine Antagonists; Flow Cytometry; Levodopa; Melanins; Microbial Sensitivity Tests; Trifluoperazine | 1996 |
Inhibition of calcium-independent luminal uptake of L-dopa by calmodulin antagonists in immortalized rat capillary cerebral endothelial cells.
Topics: Amino Acids, Cyclic; Aminoisobutyric Acids; Animals; Biological Transport; Calcium Channels, L-Type; Calmodulin; Cell Line; Cell Survival; Cyclic AMP-Dependent Protein Kinases; Cyclic GMP-Dependent Protein Kinases; Endothelium, Vascular; Enzyme Inhibitors; Hydrogen-Ion Concentration; Imidazoles; Inhibitory Concentration 50; Levodopa; Protein Kinase C; Protein-Tyrosine Kinases; Rats; Signal Transduction; Sodium; Telencephalon; Time Factors; Trifluoperazine | 2001 |
Regulation of apical transporter of L-DOPA in human intestinal Caco-2 cells.
Topics: 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Biological Transport; Caco-2 Cells; Calmodulin; Cell Polarity; Dose-Response Relationship, Drug; Humans; Imidazoles; Inhibitory Concentration 50; Levodopa; Logistic Models; Membrane Transport Proteins; Time Factors; Trifluoperazine | 2002 |